What’s Good? Dr. Ndhlovu, The New amfAR Scientific Advisory Committee Chair, Believes Teamwork Will Help Find A Cure For HIV
This is a new series where we highlight good news that exemplifies one or more of Bloomerang’s core values: empathy, innovation, stewardship, unity, equity, and transparency.
What’s good? Dr. Lishomwa “Lish” Ndhlovu, M.D., Ph.D., is amfAR’s newly-appointed Scientific Advisory Committee Chair. In a recent interview, he explained that he’s prioritizing teamwork and “thinking outside the box” in the search for a cure for HIV.
Value(s): Unity
Area impacted: Healthcare | See how we help healthcare organizations move their mission forward.
Earlier this year, the World Health Organization shared a new report about a woman whose HIV is in remission after submitting to a dual stem cell transplant. But that’s not all. The therapy also led to the woman entering remission for her acute myelogenous leukemia. Previously, there were only two men—known as the Berlin patient and the London patient—who saw an HIV cure or remission.
These are incredibly exciting advancements that point to a future where we see even more progress in HIV cure research—progress that Dr. Lishomwa “Lish” Ndhlovu, M.D., Ph.D. believes will come through teamwork and unity.
Dr. Ndhlovu, amfAR’s newly-appointed Scientific Advisory Committee Chair, shared how he plans to work toward an HIV cure.
“I’m happy to add my personal ideas to other ideas…in terms of improving the lives of people with HIV. But obviously the primary goal is to focus on a cure, so we’ll all do our best to push that agenda,” said Dr. Ndhlovu.
He continued: “We have to think outside the box with this virus and teamwork is key. I think it’s going to be exciting to see if we can put our heads together and address this complex issue together.”
Dr. Ndhlovu is also the director of the Laboratory of HIV Immunopathogenesis and Emerging Pathogens at Weill Cornell Medicine’s Division of Infectious Diseases, where he is Professor of Immunology in Medicine.
There’s more good news to come—and that includes yours.
Don’t miss out: We’ll continue to share good news on our blog.
Share your good news: We’d love for you to tell us about the good you’re doing. Big or small. Funny or serious. We want to hear about it! Email your good news to Claire at [email protected].
Article
Comments